p16 Expression Is Lost in Severely Atypical Cellular Blue Nevi and Melanoma Compared to Conventional, Mildly, and Moderately Atypical Cellular Blue Nevi

Table 1

Patient clinical characteristics, including age, gender, location of tumor, and follow-up data.


Diagnosis	Age	Sex	Location	Clinical follow-up

Benign CBN	21	F	Arm	N/A
Mildly atypical CBN	32	F	Leg	N/A
Mildly atypical CBN	24	M	Arm	N/A
Mildly atypical CBN	63	M	Arm	N/A
Mildly atypical CBN	28	F	Scalp	N/A
Mildly atypical CBN	87	M	Ear	N/A
Moderately atypical CBN	35	M	Scalp	N/A
Moderately atypical CBN	78	F	Face	N/A
Moderately atypical CBN	51	F	Buttock	N/A
Moderately atypical CBN	25	M	Leg	N/A
Severely atypical CBN	49	F	Back	No recurrence after 21 months
Severely atypical CBN	51	F	Leg	No follow-up since diagnosis
Severely atypical CBN	23	M	Chest	Lost to follow-up
Severely atypical CBN	38	F	Buttock	Lost to follow-up
Severely atypical CBN	57	F	Buttock	No follow-up since diagnosis
Superficial spreading melanoma	59	M	Back	No recurrence after 24 months
Superficial spreading melanoma	68	F	Arm	No recurrence after 20 months
Melanoma in transit metastasis	83	F	Arm	Metastatic disease
Spitzoid melanoma	24	F	Chest	No recurrence after 12 months
Melanoma in situ	54	M	Toe	No recurrence after 22 months
Superficial spreading melanoma	32	M	Back	No recurrence after 16 months
Superficial spreading melanoma	60	M	Back	Lost to follow-up
Superficial spreading melanoma	73	M	Neck	No recurrence after 18 months
Nevoid melanoma	56	F	Back	Lost to follow-up
Superficial spreading melanoma	22	F	Leg	No recurrence after 16 months
Spitzoid melanoma	41	M	Back	No recurrence after 22 months
Superficial spreading melanoma	23	F	Arm	No recurrence after 11 months
Malignant CBN	61	F	Foot	No recurrence after 12 months
Malignant CBN	13	M	Face	No follow-up since diagnosis
Malignant CBN	86	M	Back	In transit metastasis
Malignant CBN recurrence	66	M	Face	N/A